In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OncoVista Innovative Therapies Inc.

www.oncovista.com

Latest From OncoVista Innovative Therapies Inc.

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device

Deals Shaping the Medical Industry (12/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions

Selected Start-Ups (6/05)

In Vivo briefly summarizes the technologies of these recently founded companies: Biomarker Technologies, Flexicath, OncoVista, Rincon Pharmaceuticals, ThermopeutiX and ZooBiotic.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • OncoVista Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • OncoVista Innovative Therapies Inc.
  • Senior Management
  • Alexander L Weis, PhD, Pres. & CEO
    J. Michael Edwards, CFO
    Corey Levenson, PhD, CTO
  • Contact Info
  • OncoVista Innovative Therapies Inc.
    Phone: (210) 677-6000
    14785 Omicron Dr.
    Ste. 104
    San Antonio, TX 78245
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register